Newgenivf Group Limited Stock Performance
| NIVFW Stock | 0.05 0.0002 0.42% |
NewGenIvf Group holds a performance score of 15 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -4.15, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning NewGenIvf Group are expected to decrease by larger amounts. On the other hand, during market turmoil, NewGenIvf Group is expected to outperform it. Use NewGenIvf Group sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to analyze future returns on NewGenIvf Group.
Risk-Adjusted Performance
15 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in NewGenIvf Group Limited are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating technical and fundamental indicators, NewGenIvf Group showed solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Why Aehr Test Systems Shares Are Trading Higher By Around 14 Here Are 20 Stocks Moving Premarket - Benzinga | 10/11/2024 |
2 | NewGenIvf Group announces proposed reverse merger with EWIHL - TipRanks | 12/11/2024 |
NewGenIvf |
NewGenIvf Group Relative Risk vs. Return Landscape
If you would invest 1.75 in NewGenIvf Group Limited on September 14, 2024 and sell it today you would earn a total of 2.97 from holding NewGenIvf Group Limited or generate 169.71% return on investment over 90 days. NewGenIvf Group Limited is currently producing 6.6382% returns and takes up 34.3563% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than NewGenIvf, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
NewGenIvf Group Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NewGenIvf Group's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as NewGenIvf Group Limited, and traders can use it to determine the average amount a NewGenIvf Group's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1932
| Best Portfolio | Best Equity | NIVFW | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 34.36 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.19 actual daily | 15 85% of assets perform better |
Based on monthly moving average NewGenIvf Group is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NewGenIvf Group by adding it to a well-diversified portfolio.
About NewGenIvf Group Performance
Evaluating NewGenIvf Group's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if NewGenIvf Group has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NewGenIvf Group has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 13.34 | 14.01 | |
| Return On Tangible Assets | 0.08 | 0.06 | |
| Return On Capital Employed | 0.08 | 0.08 | |
| Return On Assets | 0.08 | 0.06 | |
| Return On Equity | 0.15 | 0.26 |
Things to note about NewGenIvf Group performance evaluation
Checking the ongoing alerts about NewGenIvf Group for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NewGenIvf Group help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NewGenIvf Group is way too risky over 90 days horizon | |
| NewGenIvf Group has some characteristics of a very speculative penny stock | |
| NewGenIvf Group appears to be risky and price may revert if volatility continues | |
| NewGenIvf Group has a very weak financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: NewGenIvf Group announces proposed reverse merger with EWIHL - TipRanks |
- Analyzing NewGenIvf Group's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NewGenIvf Group's stock is overvalued or undervalued compared to its peers.
- Examining NewGenIvf Group's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NewGenIvf Group's management team can have a significant impact on its success or failure. Reviewing the track record and experience of NewGenIvf Group's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NewGenIvf Group's stock. These opinions can provide insight into NewGenIvf Group's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for NewGenIvf Stock Analysis
When running NewGenIvf Group's price analysis, check to measure NewGenIvf Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewGenIvf Group is operating at the current time. Most of NewGenIvf Group's value examination focuses on studying past and present price action to predict the probability of NewGenIvf Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewGenIvf Group's price. Additionally, you may evaluate how the addition of NewGenIvf Group to your portfolios can decrease your overall portfolio volatility.